Internet-based Talking About Risk and Adolescent Choices: Health and Emotion Regulation Options
iTRAC-HERO
Interactive Emotion Regulation Skills Training to Improve Adolescent Health Ph II
2 other identifiers
interventional
120
1 country
1
Brief Summary
Using the efficacious iTRAC intervention to enhance emotion regulation competencies as a foundation, this study will create and test iTRAC-HERO to teach emotion regulation skills in the context of sexual health education.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 26, 2025
CompletedFirst Posted
Study publicly available on registry
March 25, 2025
CompletedStudy Start
First participant enrolled
April 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 8, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 31, 2026
March 31, 2026
March 1, 2026
1.2 years
February 26, 2025
March 30, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in Sexual Self-Efficacy (SSE) from baseline to 6 months.
The Sexual Self-Efficacy Scale (12 items) will measure self-efficacy for safer sexual activity as a main outcome which will indicate iTRAC-HERO's efficacy and ability to promote healthier sexual behaviors with the full sample (not just those who are sexually active).
Baseline, 1 month post-intervention, 6 month follow up
Change in Self Efficacy for HIV Prevention from baseline to 6 month.
The Self-Efficacy for HIV Prevention Scale (12 items) assesses a range of behaviors related to prevention of HIV, other STIs, or unintended pregnancy, including refusing sexual behaviors, discussing sexual histories with partners, buying condoms, taking free condoms, carrying condoms, and asking a partner to use a condom.
Baseline, 1 month post-intervention, 6 month follow up
Secondary Outcomes (4)
Change in Sexual Risk Cognition from baseline to 6 months
Baseline, 1 month post-intervention, 6 month follow up
Change in attitudes towards abstinence from baseline to 6 months
Baseline, 1 month post-intervention, 6 month follow up
Change in frequency of sexual and substance use behaviors from baseline to 6 months
Baseline, 1 month post-intervention, 6 month follow up
Change in adolescent substance use behaviors from baseline to 6 months
Baseline, 1 month post-intervention, 6 month follow up
Other Outcomes (5)
Change in Emotion Regulation Skills from baseline to 6 months
Baseline, 1 month post-intervention, 6 month follow up
Change in frequency of dificulties with emotion regulation from baseline to 6 months
Baseline, 1 month post-intervention, 6 month follow up
Change in usage of emotion regulation behaviors taught in iTRAC-HERO from baseline to 6 months
Baseline, 1 month post-intervention, 6 month follow up
- +2 more other outcomes
Study Arms (2)
Waitlist Control
NO INTERVENTIONControl participants will be assessed on the same schedule as the treatment condition and offered the intervention after 6-month follow-up.
iTRAC-HERO
EXPERIMENTALiTRAC-HERO is an 8-module, web-based intervention for middle school boys and girls to complete. Its goal is primary prevention of adolescent sexual risk behaviors by targeting emotion regulation and sexual self-efficacy. (e.g., to refuse sexual advances).
Interventions
iTRAC-HERO will consist of eight, approximately 45-minute, "gamified" digital modules of 4-6 activities (games, videos, etc.). No instruction is needed to use the program. Content will use gender- and sexuality-inclusive language and avoid heteronormative descriptions of risk. This content will include strategies for (and practice with) recognizing and managing emotions, particularly in relation to sexual health situations, to enhance the likelihood that the emotion regulation and sexual health education provided can be applied to experiences that are emotionally arousing and lead to risk.
Eligibility Criteria
You may qualify if:
- Attending 7th grade
- Between 12 and 14 years old
- Parent/guardian speaks English or Spanish
- Attending participating school
You may not qualify if:
- Unable to read at a 4th grade level
- Have a sibling who has participated in the study
- Have a development disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)collaborator
- Klein Buendel, Inc.lead
- Rhode Island Hospitalcollaborator
- University of Oregoncollaborator
Study Sites (1)
Klein Buendel, Inc.
Golden, Colorado, 80401, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christopher Houck, PhD
Rhode Island Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 26, 2025
First Posted
March 25, 2025
Study Start
April 1, 2025
Primary Completion (Estimated)
June 8, 2026
Study Completion (Estimated)
August 31, 2026
Last Updated
March 31, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
- Time Frame
- After analyses are completed for the aims of the study.
- Access Criteria
- The data package will be available for future investigators. For datasets that include potentially sensitive information, investigators not part of the original study will submit requests to be reviewed by the PIs. Qualified investigators who agree to terms of use and confidentiality agreements will be provided with deidentified data.
The investigators will prepare an archival-quality data package for upload to the National Institute of Child Health and Human Development (NICHD) Data and Specimen Hub (DASH). Specifically, the investigators will provide documentation on the full data-audit trail from the exact prompts seen by participants, to the syntax used to score and aggregate items, to the finalized data ready for use by qualified investigators. The archival-quality data package will also include a codebook in line with the Data Documentation Initiative (DDI) and contains information about variables, metadata, and file structure. The metadata will include description of the trial, including design, implementation, and description of the interventions. The intent is to provide everything that future investigators require to understand the trial, analyze the data, correctly interpret the findings, and be able to publish new analyses that meet current publication standards for clinical trials and/or meta-analyses.